VetRec
-84%
est. 2Y upside i
AI Scribe for veterinarians. Saving time and improving patient care.
Rank
#408
Sector
HealthTech, AI, SaaS
Est. Liquidity
~6Y
Data Quality
Data: LowVetRec offers a compelling opportunity in a niche, high-growth market addressing a critical pain point for veterinarians, but job seekers must weigh the significant early-stage risks and strong incumbent competition against the potential for substantial upside if the company successfully scales.
Last updated: February 15, 2026
VetRec achieves significant market penetration, secures substantial Series A/B funding, and demonstrates strong revenue growth, leading to a favorable acquisition by a major HealthTech or veterinary industry player.
VetRec continues to grow steadily, expands its customer base and product features, but faces increased competition or slower-than-expected market adoption, resulting in a modest acquisition or further funding at a reasonable valuation.
VetRec struggles to scale, incumbents successfully replicate its core functionality, or funding becomes challenging, leading to a distressed sale or eventual shutdown.
Community
Valuation Sentiment
Our model estimates -84% upside. What do you think?
Anonymous. Do not share material non-public information.
Community Discussion
Comments are reviewed before they appear publicly.
Loading comments...
Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.